Last reviewed · How we verify
NCT06810479: MRA OSA
A Study Comparing Two Mandibular Advancement Devices in the Treatment of Sleep Apnea
NA trial testing Polygraphy in Apnea, Obstructive in 20 participants. Not yet recruiting.
31 January 2026
Quick facts
| Lead sponsor | Ziekenhuis Oost-Limburg |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 20 March 2025 |
| Primary completion | 31 January 2026 |
| Estimated completion | 1 April 2026 |
Drugs / interventions tested
- Polygraphy
- Questionaire
- Questionaire
- Question
Conditions studied
- Apnea, Obstructive — all drugs for Apnea, Obstructive →
Sponsor
Ziekenhuis Oost-Limburg — full company profile →
Who can join
18 and older, any sex, with Apnea, Obstructive. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this randomised, controlled cross-over study is to compare two mandibular repositioning devices (MRA) already on the market in the treatment of mild-to-moderate obstructive sleep apnea. Patiënt will test the first MRA for 3 months, after a wash out period of 2 weeks they will test the second MRA for 3 months. It will be randomised what type of MRA will be tested first and second.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06810479
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Polygraphy
Trials testing the same drug.
- NCT05204004 — The Sunrise OSA Trial · NA · completed
- NCT04448470 — Daytime Sleepiness in Patients With the Assessment of a Sleep-related Respiratory Disorder · unknown
- NCT04002739 — PRedictOrs, PHEnotypes and Timing of Obstructive Sleep Apnea in Acute Coronary Syndrome · NA · unknown
Other recruiting trials for Apnea, Obstructive
Currently open trials in the same condition.
- NCT06462287 — EFFECT OF A SUBSTANCE P ANTAGONIST ON THE SECRETION OF ALDOSTERONE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME AND · Phase 2 · recruiting
- NCT04950894 — Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation · NA · active not recruiting
- NCT04179188 — Impact of Bariatric Surgery in Obese Patients With and Without Obstructive Sleep Apnea Syndrome · recruiting
Other Ziekenhuis Oost-Limburg trials
Trials by the same sponsor.
- NCT07281534 — Test-Retest Reliability of Cardiopulmonary Exercise Testing With Echocardiography · NA · recruiting
- NCT07123818 — AI for Detection of Brain Aneurysm: Low-cost Opportunistic Screening · NA · active not recruiting
- NCT06994091 — Imaging Comparison for the Preoperative Planning and Diagnosis of DIE: a Multicenter Retrospective Study. · not yet recruiting
- NCT06185608 — The Effects of Various Concentrations of Ropivacaine on the Onset and Duration of Ankle Blocks · NA · recruiting
- NCT06479005 — ETERNALS: Remote Monitoring in Lung Cancer Patients · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06810479 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ziekenhuis Oost-Limburg
- Last refreshed: 21 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06810479.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing